GEM-231 Completed Phase 1 Trials for Unspecified Adult Solid Tumor, Protocol Specific Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00004863Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00004864Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors